EQH:NYSEEquitable Holdings, Inc. Analysis
Data as of 2026-08-03 - not real-time
$47.65
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
EQH is trading at $47.65, comfortably above its immediate support of $45.37 but still below the 20‑day SMA of $48.00. The 20‑day SMA sits above the 50‑day SMA ($44.99), indicating a short‑term bullish bias despite a bearish MACD histogram. Momentum is neutral with an RSI of 52.7, suggesting no immediate overbought or oversold pressure. Volatility remains elevated at over 31% on a 30‑day basis and a beta of ~1.2, implying the stock moves more aggressively than the market. The forward PE of 5.34 is dramatically lower than the industry average of 18.0, positioning EQH as a deep value play.
A discounted cash‑flow model values the company at roughly $51.6, providing an upside of nearly 27% versus the current price. The dividend yield of 2.39% and a payout ratio near 77% add income appeal, though free cash flow is currently negative. Revenue is contracting at -7.6% YoY and profit margins remain in the red, highlighting ongoing operational challenges. The balance sheet shows a high debt‑to‑equity ratio of over 300% and a negative book value per share, which caps the margin of safety. Recent news confirms a dividend declaration and an upcoming Q2 earnings release, which could catalyze short‑term price movement.
A discounted cash‑flow model values the company at roughly $51.6, providing an upside of nearly 27% versus the current price. The dividend yield of 2.39% and a payout ratio near 77% add income appeal, though free cash flow is currently negative. Revenue is contracting at -7.6% YoY and profit margins remain in the red, highlighting ongoing operational challenges. The balance sheet shows a high debt‑to‑equity ratio of over 300% and a negative book value per share, which caps the margin of safety. Recent news confirms a dividend declaration and an upcoming Q2 earnings release, which could catalyze short‑term price movement.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price above immediate support
- bearish MACD signal
- stable trading volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside to $51.6
- forward PE advantage over peers
- attractive dividend yield
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- high debt‑to‑equity ratio
- negative free cash flow
- diversified financial services platform
Key Metrics & Analysis
Financial Health
Revenue Growth-7.60%
Profit Margin-7.26%
P/E Ratio5.3
ROE-13.52%
ROA-0.05%
Debt/Equity321.16
P/B Ratio-16.9
Op. Cash Flow$1.1B
Free Cash Flow$-9287000064
Industry P/E18.0
Technical Analysis
TrendBullish
RSI52.7
Support$45.37
Resistance$50.03
MA 20$48.00
MA 50$44.99
MA 200$44.20
MACDBearish
VolumeStable
Fear & Greed Index92.88
Valuation
Fair Value$51.61
Target Price$60.82
Upside/Downside27.64%
GradeUndervalued
TypeBlend
Dividend Yield2.39%
Risk Assessment
Beta1.20
Volatility31.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.